Analytical method development and validation for the simultaneous estimation of Rosuvastatin and Finofibate in tablet dosage form by reverse phase high performance liquid chromatography

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2013, Vol 1, Issue 6

Abstract

A new, simple, precise, accurate and reproducible RP-HPLC method for Simultaneous estimation of Rosuvastatin (ROS) and Fenofibrate (FEN) in bulk and pharmaceutical formulations was developed. Separation of ROS and FEN was successfully achieved on a Hypersil C18 (4.6 x 250mm, 6.5 m, Make: Waters) or equivalent in an isocratic mode utilizing OPA buffer (pH 3.0): Methanol (65:35%v/v) at a flow rate of 1.2 mL/min and eluate was monitored at 238 nm, with a retention time of 1.950 and 3.858 minutes for ROS and FEN. The method was validated and the response was found to be linear in the drug concentration range of 50 µg/mL to 150 µg/mL for ROS and 50 µg/mL to 150 µg/mL for FEN. The values of the slope, intercept and the correlation coefficient were found to be 2 2 507, 7467 and 0.999 for ROS and 21157, 16980 and 0.999 for FEN respectively. The LOD and LOQ for Rosuvastatine were found to be 0.0053, 0.017 respectivly. The LOD and LOQ for Fenofibrate were found to be 0.00019, 0.00063 respectively. This method was found to be good percentage recovery for Rosuvastatine and Fenofibrate were found to be 99.00 and 99.00 respectively indicates that the proposed method is highly accurate. The specificity of the method shows good correlation between retention times of standard with the sample so, the method specifically determines the analyte in the sample without interference from excipients of tablet dosage forms. The method was extensively validated according to ICH guidelines for Linearity, Range, Accuacy, Precesion, Specificity and Robustness.

Authors and Affiliations

M. Sumalatha, K. Haritha Pavani

Keywords

Related Articles

Formulation and evaluation of vildagliptin sustained release tablets

The main aim of proposed work was to develop Vildagliptin matrix tablets, sustained release dosage form, for the treatment anti-diabetic drug. Sustained release formulation is the drug delivery system that is designed...

A Survey on medicinal plant usage by folk medicinal practitioners in different villages of Haluaghat Upazila, Mymensingh District, Bangladesh

Medicinal plants are an important and often the only component in the formulations used by the folk medicinal practitioners of Bangladesh for treatment of various ailments. Folk medicinal practitioners (Kavirajes) are...

Formulation and evaluation of colon targeted Aceclofenac tablets

Aceclofenac colon targeted tablets were prepared by using natural polymers like guar gum and Locust bean gum. Matrix core tablets were prepared by using various concentrations of polymers. The core tablets were coated...

EFFECTS OF PERMEABILITY CHARACTERISTICS OF DIFFERENT POLYMETHACRYLATES ON THE PHARMACEUTICAL CHARACTERISTICS OF DILTIAZEM HCL-LOADED MICROSPHERES

Microspheres containing Diltiazem hydrochloride (DTZ Hcl) were prepared with various Polymethacrylates, with different permeability characteristics (Eudragit RSPO and Eudragit RLPO) and also with mixtures of these poly...

Development of new RP-HPLC method for the simultaneous estimation of Satranidazole and Oflaxacin pharmaceutical dosage form

A simple and selective LC method is described for the determination of Satranidazole and Ofloxacin in tablet dosage forms. Chromatographic separation was achieved on a c18 column using mobile phase consisting of a mixt...

Download PDF file
  • EP ID EP33156
  • DOI -
  • Views 282
  • Downloads 0

How To Cite

M. Sumalatha, K. Haritha Pavani (2013). Analytical method development and validation for the simultaneous estimation of Rosuvastatin and Finofibate in tablet dosage form by reverse phase high performance liquid chromatography. Indian Journal of Research in Pharmacy and Biotechnology, 1(6), -. https://europub.co.uk/articles/-A-33156